Showing 641 - 660 results of 105,137 for search '(( e non decrease ) OR ( 5 ((((wt decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.72s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645
  6. 646

    Systemic inhibition of TGF-β decreases retinal smad2 phosphorylation <i>in vivo</i>. by Tony E. Walshe (269700)

    Published 2013
    “…(D) Higher magnification of ppsmad2 staining in control mice, demonstrating nuclear pp-smad2 in retinal ECs (arrow). Scale = 20 µm. (E) Western blot analysis of pp-smad2, smad2, pp-smad1/5/8 and GAPDH in mouse retinas from Ad-null and Ad-sEng-expressing mice (day 7). sEng-expressing mice displayed a decrease in retinal pp-smad2 (F). …”
  7. 647
  8. 648

    <i>tra</i> regulates growth in a cell-autonomous, and a non cell-autonomous manner. by Elizabeth J. Rideout (651946)

    Published 2016
    “…(D) Expression of a <i>tra2-RNAi</i> transgene in the posterior compartment of the wing using <i>en-GAL4</i> caused a significant reduction in the ratio of posterior:anterior (p = 1.5 x 10<sup>−6</sup>; Student’s t-test). …”
  9. 649
  10. 650
  11. 651
  12. 652
  13. 653
  14. 654
  15. 655

    Image 5_G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo.tif by Nuzhat Rahman (16660416)

    Published 2024
    “…</p>Methods<p>Mice were inoculated with 10<sup>7</sup> CFU of the eubiotic bacteria Lactobacillus crispatus, the dysbiotic bacteria G. vaginalis, or PBS as a negative control every 48 h for ten days. On day ten, mice were inoculated with 10<sup>5</sup> PFU WT HSV-2 333 and survival, pathology, and viral titers were assessed. …”
  16. 656
  17. 657
  18. 658

    Image5_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

    Published 2024
    “…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”
  19. 659
  20. 660